Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001102624-14-001896

Options or other derivatives

  • Director acquired 12,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BAXTER GREGORY T. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2014-11-12 Grant or award : show line 1 in the form Stock Option (Right To Buy) +12,500 12,500 D
Loading xslF345X03/primary_doc.xml…